Short Summary: How dietary sugar (fructose) affects the growth rate of cancer.
About the guest: Gary Patti, PhD is a professor at Washington University in St. Louis, holding appointments in chemistry, medicine, and genetics
Note: Podcast episodes are fully available to paid subscribers on the M&M Substack and everyone on YouTube. Partial versions are available elsewhere. Full transcript and other information on Substack.
Episode Summary: Nick Jikomes talks to Dr. Gary Patti, exploring how cancer cells metabolize sugars like glucose and fructose, focusing on a recent study showing fructose indirectly boosts tumor growth in mice via liver-produced lipids called lysophosphatidylcholines (LPCs). The discussion covers cancer biology basics, the Warburg effect, tumor microenvironments, and the systemic metabolic impacts of cancer, while also touching on dietary implications, fasting, and the complexities of nutrient utilization in cancer progression.
Key Takeaways:
Cancer cells often rely heavily on glucose, excreting it as lactate even when oxygen is available (Warburg effect), but take up more than their mitochondria can handle.
In a study, high fructose diets accelerated tumor growth in mice by 4x, not because cancer cells use fructose directly, but because the liver converts it to LPCs, which tumors use to build membranes.
Tumors are not just cancer cells; they recruit healthy cells in their microenvironment, and their metabolic effects ripple across the entire body, altering distant tissues.
Excessive fructose consumption (e.g., from soda, not fruit) may worsen tumor growth, but cutting it poses little risk and could benefit cancer patients, pending human studies.
Fasting may reduce cancer initiation risk in animals, but its effect on existing tumors is less clear and could worsen wasting (cachexia) in late stages.
The body tightly regulates blood glucose via the liver, so simply cutting dietary glucose won’t starve tumors, highlighting cancer’s metabolic adaptability.
Related episode:
M&M #200: Dietary Fats & Seed Oils in Inflammation, Colon Cancer & Chronic Disease | Tim Yeatman & Ganesh Halade
*Not medical advice.
Support M&M if you find value in this content.
Episode transcript below.
Episode Chapters:
00:00:00 Intro
00:05:35 Cancer Biology Basics
00:11:26 Tumor Initiation and Immune Evasion
00:17:13 Studying Early Cancer with Zebrafish
00:23:19 Metabolic Changes in Tumors
00:29:16 Tumor Microenvironment and Healthy Cells
00:34:28 Glucose vs. Fructose Metabolism
00:40:17 Fructose and Cancer Cell Growth
00:46:04 Fructose Processing in the Body
00:52:49 High Fructose Diets in Mice
00:59:22 Liver’s Role in Tumor Growth
01:06:06 Identifying LPCs as Key Nutrient
01:12:03 LPCs and Dietary Fat Connections
01:17:19 Fructose Intake Implications
01:23:40 Endogenous Fructose and Drugs
01:27:57 Ketogenic Diets and Cancer
01:34:09 Fasting and Cancer Risk
01:39:59 Cancer Phases and Diet Strategies
Full AI-generated transcript below. Beware of typos & mistranslations!
Listen to this episode with a 7-day free trial
Subscribe to Mind & Matter to listen to this post and get 7 days of free access to the full post archives.
